Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

CDMOP

Avid Bioservices (CDMOP)

Avid Bioservices Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP
DataHoraFonteTítuloCódigoCompanhia
08/03/202119:01GlobeNewswire Inc.Avid Bioservices, Inc. Announces Proposed $125 Million Offering of Exchangeable Senior NotesNASDAQ:CDMOPAvid Bioservices Inc
08/03/202118:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDMOPAvid Bioservices Inc
08/03/202118:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2021 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
03/03/202118:05GlobeNewswire Inc.Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred StockNASDAQ:CDMOPAvid Bioservices Inc
01/03/202118:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021NASDAQ:CDMOPAvid Bioservices Inc
22/02/202110:05GlobeNewswire Inc.Avid Bioservices Begins Phase 2 of its Myford Manufacturing Capacity Expansion PlanNASDAQ:CDMOPAvid Bioservices Inc
16/02/202117:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDMOPAvid Bioservices Inc
03/02/202109:00GlobeNewswire Inc.Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Suppo...NASDAQ:CDMOPAvid Bioservices Inc
03/02/202109:00Business WireHumanigen & Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support...NASDAQ:CDMOPAvid Bioservices Inc
04/01/202120:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
14/12/202018:05GlobeNewswire Inc.Avid Bioservices Announces Closing of Public Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
11/12/202019:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CDMOPAvid Bioservices Inc
10/12/202011:00GlobeNewswire Inc.Avid Bioservices Announces Pricing of Public Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
09/12/202018:45GlobeNewswire Inc.Avid Bioservices Announces Proposed Public Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
07/12/202018:05GlobeNewswire Inc.Avid Bioservices Announces Appointment of Jeanne Thoma to Board of DirectorsNASDAQ:CDMOPAvid Bioservices Inc
02/12/202018:37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDMOPAvid Bioservices Inc
02/12/202018:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
24/11/202018:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020NASDAQ:CDMOPAvid Bioservices Inc
15/09/202017:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CDMOPAvid Bioservices Inc
15/09/202017:05GlobeNewswire Inc.Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020NASDAQ:CDMOPAvid Bioservices Inc
10/09/202009:05GlobeNewswire Inc.Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:CDMOPAvid Bioservices Inc
01/09/202017:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
27/08/202018:52Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CDMOPAvid Bioservices Inc
26/08/202009:05GlobeNewswire Inc.Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibo...NASDAQ:CDMOPAvid Bioservices Inc
25/08/202017:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2021 After Market Close on September 1, 2020NASDAQ:CDMOPAvid Bioservices Inc
20/08/202009:30Business WireOragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus VaccineNASDAQ:CDMOPAvid Bioservices Inc
06/08/202009:05GlobeNewswire Inc.Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Ana...NASDAQ:CDMOPAvid Bioservices Inc
31/07/202020:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDMOPAvid Bioservices Inc
28/07/202009:05GlobeNewswire Inc.Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integr...NASDAQ:CDMOPAvid Bioservices Inc
22/07/202018:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CDMOPAvid Bioservices Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP